30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.

ABSTRACT:

Background

30-day mortality might be a useful indicator of avoidable harm to patients from systemic anticancer treatments, but data for this indicator are limited. The Systemic Anti-Cancer Therapy (SACT) dataset collated by Public Health England allows the assessment of factors affecting 30-day mortality in a national patient population. The aim of this first study based on the SACT dataset was to establish national 30-day mortality benchmarks for breast and lung cancer patients receiving SACT in England, and to start to identify where patient care could be improved.

Methods

In this population-based study, we included all women with breast cancer and all men and women with lung cancer residing in England, who were 24 years or older and who started a cycle of SACT in 2014 irr

SUBMITTER: Wallington M 

PROVIDER: S-EPMC5027226 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature